| Expression pattern: |
DN |
| Associated gene: |
BTG2, FAK |
| Associated microRNA: |
miR-15a-5p |
| Biological function: |
inhibits proliferation, invasion, and migration of gastric cancer cells; inhibits tumor growth in vivo |
| Molecular mechanism: |
ceRNA mechanism: hsa_circ_0069382 sponges miR-15a-5p to upregulate BTG2 and downregulate FAK (BTG2/FAK axis) |
| Biological pathway or process: |
proliferation (inhibits); migration (inhibits); invasion (inhibits); ceRNA regulation (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; RNase R Treatment; Back-Splice Junction PCR / divergent primers PCR; FISH / smFISH; Luciferase Reporter Assay; Transfection; CCK8; Wound Healing Assay; Transwell Assay; Colony Formation Assay; Western Blot; In Vivo Animal Model; Clinical Sample Validation; Bioinformatics Analysis |
| Clinical significance: |
potential diagnostic biomarker and therapeutic target for gastric cancer |
| Description: |
hsa_circ_0069382 is down-regulated in gastric cancer tissues/cell lines. Its overexpression suppresses gastric cancer cell proliferation, migration and invasion and reduces xenograft tumor growth, mainly by sponging miR-15a-5p to modulate the BTG2/FAK axis. |
| Confidence score: |
0.7897 |